|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 59.81 USD | -0.71% |
|
-4.94% | +2.03% |
| Mar. 09 | JBS workers to strike at US beef plant as consumers face record prices | RE |
| Mar. 04 | Tyson Foods Expands Athletics Sponsorship With University of Arkansas | MT |
| Fiscal Period: September | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 8.4 | 7.53 | 1.35 | 3 | 2.57 | |||||
Return on Total Capital | 10.81 | 9.78 | 1.73 | 3.84 | 3.33 | |||||
Return On Equity % | 18.41 | 17.25 | -3.41 | 4.47 | 2.76 | |||||
Return on Common Equity | 18.48 | 17.3 | -3.43 | 4.38 | 2.6 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 14.58 | 12.43 | 5.57 | 7.42 | 6.69 | |||||
SG&A Margin | 4.48 | 4.16 | 4.08 | 4.11 | 3.91 | |||||
EBITDA Margin % | 12.65 | 10.51 | 4.01 | 5.91 | 5.19 | |||||
EBITA Margin % | 10.66 | 8.73 | 1.92 | 3.73 | 3.26 | |||||
EBIT Margin % | 10.11 | 8.27 | 1.49 | 3.31 | 2.79 | |||||
Income From Continuing Operations Margin % | 6.5 | 6.1 | -1.23 | 1.54 | 0.93 | |||||
Net Income Margin % | 6.48 | 6.08 | -1.23 | 1.5 | 0.87 | |||||
Net Avail. For Common Margin % | 6.48 | 6.08 | -1.23 | 1.5 | 0.87 | |||||
Normalized Net Income Margin | 5.79 | 4.75 | 0.58 | 1.61 | 1.26 | |||||
Levered Free Cash Flow Margin | 6.89 | 0.48 | -0.12 | 2.57 | 2.18 | |||||
Unlevered Free Cash Flow Margin | 7.42 | 0.89 | 0.28 | 3.11 | 2.68 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.33 | 1.46 | 1.45 | 1.45 | 1.48 | |||||
Fixed Assets Turnover | 5.7 | 6.07 | 5.46 | 5.24 | 5.38 | |||||
Receivables Turnover (Average Receivables) | 21.62 | 21.41 | 20.93 | 21.84 | 22.09 | |||||
Inventory Turnover (Average Inventory) | 9.75 | 9.43 | 9.21 | 9.38 | 9.34 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.55 | 1.81 | 1.34 | 2.04 | 1.55 | |||||
Quick Ratio | 0.78 | 0.68 | 0.47 | 0.86 | 0.59 | |||||
Operating Cash Flow to Current Liabilities | 0.61 | 0.51 | 0.27 | 0.54 | 0.34 | |||||
Days Sales Outstanding (Average Receivables) | 16.83 | 17 | 17.39 | 16.67 | 16.48 | |||||
Days Outstanding Inventory (Average Inventory) | 37.32 | 38.6 | 39.52 | 38.8 | 38.97 | |||||
Average Days Payable Outstanding | 18.33 | 17.93 | 18.57 | 18.47 | 17.76 | |||||
Cash Conversion Cycle (Average Days) | 35.82 | 37.67 | 38.33 | 37 | 37.69 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 55.29 | 44.5 | 54.97 | 56.61 | 53.19 | |||||
Total Debt / Total Capital | 35.6 | 30.8 | 35.47 | 36.15 | 34.72 | |||||
LT Debt/Equity | 48.44 | 41.45 | 43.75 | 55.28 | 47.1 | |||||
Long-Term Debt / Total Capital | 31.2 | 28.69 | 28.23 | 35.3 | 30.75 | |||||
Total Liabilities / Total Assets | 50.83 | 46.2 | 49.64 | 50.1 | 50.28 | |||||
EBIT / Interest Expense | 11.11 | 12.07 | 2.22 | 3.66 | 3.38 | |||||
EBITDA / Interest Expense | 15.51 | 17.29 | 8.08 | 8.1 | 8.09 | |||||
(EBITDA - Capex) / Interest Expense | 12.69 | 12.12 | 2.62 | 5.74 | 5.92 | |||||
Total Debt / EBITDA | 1.49 | 1.4 | 3.5 | 2.69 | 2.67 | |||||
Net Debt / EBITDA | 1.09 | 1.22 | 3.26 | 2.22 | 2.3 | |||||
Total Debt / (EBITDA - Capex) | 1.82 | 1.99 | 10.79 | 3.79 | 3.65 | |||||
Net Debt / (EBITDA - Capex) | 1.34 | 1.74 | 10.06 | 3.13 | 3.14 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 8.95 | 13.25 | -0.75 | 0.81 | 2.12 | |||||
Gross Profit, 1 Yr. Growth % | 16.27 | 0.26 | -55.53 | 34.99 | -7.84 | |||||
EBITDA, 1 Yr. Growth % | 21.13 | -1.72 | -62.17 | 51.3 | -10.22 | |||||
EBITA, 1 Yr. Growth % | 25.02 | -2.29 | -78.12 | 98.9 | -10.9 | |||||
EBIT, 1 Yr. Growth % | 27.34 | -2.09 | -82.1 | 128.24 | -13.9 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 47.75 | 6.18 | -119.98 | -226.66 | -38.32 | |||||
Net Income, 1 Yr. Growth % | 47.84 | 6.27 | -120.01 | -223.46 | -40.75 | |||||
Normalized Net Income, 1 Yr. Growth % | 33.19 | -1.34 | -87.83 | 188.86 | -20.13 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 47.87 | 6.95 | -120.96 | -220.32 | -40.92 | |||||
Accounts Receivable, 1 Yr. Growth % | 22.95 | 7.38 | -3.92 | -2.83 | 4.9 | |||||
Inventory, 1 Yr. Growth % | 13.55 | 25.83 | -3.37 | -2.5 | 9.36 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 2.95 | 9.85 | 10.73 | -0.26 | -0.6 | |||||
Total Assets, 1 Yr. Growth % | 5.38 | 1.41 | -1.55 | 2.34 | -1.19 | |||||
Tangible Book Value, 1 Yr. Growth % | -127.08 | 348.4 | -26.56 | 24.99 | 10.98 | |||||
Common Equity, 1 Yr. Growth % | 16.19 | 11.17 | -7.96 | 1.42 | -1.66 | |||||
Cash From Operations, 1 Yr. Growth % | -0.88 | -30.03 | -34.8 | 47.83 | -16.8 | |||||
Capital Expenditures, 1 Yr. Growth % | 0.83 | 56.08 | 2.76 | -41.62 | -13.6 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 26.93 | -91.65 | -124 | -1.6K | -13.23 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 22.76 | -85.76 | -68.35 | 1.28K | -12.08 | |||||
Dividend Per Share, 1 Yr. Growth % | 5.95 | 3.37 | 4.35 | 2.08 | 2.04 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 5.33 | 11.08 | 6.02 | 0.03 | 1.46 | |||||
Gross Profit, 2 Yr. CAGR % | 16.41 | 10.92 | -32.81 | -22.99 | 11.54 | |||||
EBITDA, 2 Yr. CAGR % | 22.87 | 14.23 | -38.58 | -25.28 | 16.55 | |||||
EBITA, 2 Yr. CAGR % | 26.75 | 17.16 | -53.37 | -34.89 | 33.12 | |||||
EBIT, 2 Yr. CAGR % | 29.05 | 19 | -57.75 | -37.08 | 40.18 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 23.91 | 25.25 | -53.95 | -49.7 | -11.61 | |||||
Net Income, 2 Yr. CAGR % | 24.05 | 25.34 | -53.88 | -50.29 | -14.47 | |||||
Normalized Net Income, 2 Yr. CAGR % | 34.26 | 23.62 | -65 | -42.05 | 48.49 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 24.28 | 25.76 | -52.65 | -49.78 | -23.72 | |||||
Accounts Receivable, 2 Yr. CAGR % | 5.09 | 14.9 | 1.57 | -3.37 | 0.96 | |||||
Inventory, 2 Yr. CAGR % | 5.61 | 19.54 | 10.27 | -2.94 | 3.26 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 7.2 | 6.34 | 10.29 | 5.09 | -0.43 | |||||
Total Assets, 2 Yr. CAGR % | 5.02 | 3.37 | -0.08 | 0.38 | 0.56 | |||||
Tangible Book Value, 2 Yr. CAGR % | -59.18 | 10.19 | 81.47 | -4.19 | 17.78 | |||||
Common Equity, 2 Yr. CAGR % | 12.71 | 13.65 | 1.15 | -3.39 | -0.13 | |||||
Cash From Operations, 2 Yr. CAGR % | 23.61 | -16.72 | -32.45 | -1.82 | 10.91 | |||||
Capital Expenditures, 2 Yr. CAGR % | -2.01 | 25.45 | 26.64 | -22.55 | -28.98 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 129.65 | -65.53 | -85.73 | 119.24 | 260.5 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 97.87 | -56.03 | -78.61 | 81.72 | 247.74 | |||||
Dividend Per Share, 2 Yr. CAGR % | 8.93 | 4.65 | 3.86 | 3.21 | 2.06 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 5.51 | 7.91 | 6.98 | 4.25 | 0.72 | |||||
Gross Profit, 3 Yr. CAGR % | 9.7 | 9.37 | -18.21 | -15.38 | -18.24 | |||||
EBITDA, 3 Yr. CAGR % | 13.36 | 12.41 | -20.96 | -17.53 | -20.56 | |||||
EBITA, 3 Yr. CAGR % | 14.27 | 14.23 | -33.03 | -24.8 | -27.72 | |||||
EBIT, 3 Yr. CAGR % | 14.69 | 15.57 | -36.71 | -26.4 | -30.15 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 0.97 | 17.69 | -32.08 | -35.48 | -46.16 | |||||
Net Income, 3 Yr. CAGR % | 0.86 | 17.82 | -32 | -35.97 | -47.3 | |||||
Normalized Net Income, 3 Yr. CAGR % | 15.51 | 18.75 | -42.91 | -30.09 | -35.51 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 1.23 | 18.21 | -30.79 | -35.38 | -47 | |||||
Accounts Receivable, 3 Yr. CAGR % | 11.68 | 5.85 | 8.25 | 0.08 | -0.69 | |||||
Inventory, 3 Yr. CAGR % | 7.65 | 11.96 | 11.35 | 5.84 | 1 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 10.7 | 8.07 | 7.79 | 6.65 | 3.16 | |||||
Total Assets, 3 Yr. CAGR % | 7.65 | 3.81 | 1.71 | 0.72 | -0.15 | |||||
Tangible Book Value, 3 Yr. CAGR % | -43.83 | -9.26 | -3.75 | 60.26 | 0.62 | |||||
Common Equity, 3 Yr. CAGR % | 11.45 | 12.2 | 5.93 | 1.24 | -2.81 | |||||
Cash From Operations, 3 Yr. CAGR % | 9.03 | 2.26 | -23.24 | -12.3 | -7.09 | |||||
Capital Expenditures, 3 Yr. CAGR % | 0.25 | 14.44 | 17.38 | -2.17 | -19.67 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 15.99 | -25.2 | -69.45 | -23.29 | 60.96 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 15.14 | -18.96 | -60.6 | -20.36 | 42.66 | |||||
Dividend Per Share, 3 Yr. CAGR % | 14.05 | 7.05 | 4.55 | 3.26 | 2.82 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 4.99 | 6.85 | 5.71 | 4.68 | 4.74 | |||||
Gross Profit, 5 Yr. CAGR % | 7.87 | 5.2 | -10.73 | -4.82 | -7.51 | |||||
EBITDA, 5 Yr. CAGR % | 11.01 | 7.6 | -12.31 | -4.38 | -8 | |||||
EBITA, 5 Yr. CAGR % | 11.48 | 7.51 | -21.25 | -8.6 | -12.15 | |||||
EBIT, 5 Yr. CAGR % | 10.91 | 7.06 | -24.2 | -9.2 | -13.39 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 11.55 | 12.81 | -26.24 | -16.23 | -24.53 | |||||
Net Income, 5 Yr. CAGR % | 11.5 | 12.79 | -26.25 | -16.58 | -25.47 | |||||
Normalized Net Income, 5 Yr. CAGR % | 10.94 | 7.11 | -29.49 | -10.68 | -16.16 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 12.98 | 13.24 | -25.3 | -16.06 | -25.12 | |||||
Accounts Receivable, 5 Yr. CAGR % | 9.25 | 9 | 7.52 | 2.06 | 5.27 | |||||
Inventory, 5 Yr. CAGR % | 9.91 | 11.23 | 8.69 | 5.75 | 8.04 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 10.11 | 10.55 | 10.53 | 6.87 | 4.42 | |||||
Total Assets, 5 Yr. CAGR % | 10.17 | 5.58 | 4.49 | 2.42 | 1.25 | |||||
Tangible Book Value, 5 Yr. CAGR % | -21.12 | -10.19 | -10.21 | -7.27 | 4.34 | |||||
Common Equity, 5 Yr. CAGR % | 13.03 | 13.32 | 7.21 | 5.68 | 3.46 | |||||
Cash From Operations, 5 Yr. CAGR % | 7.17 | 0.67 | -9.98 | 0.61 | -11.07 | |||||
Capital Expenditures, 5 Yr. CAGR % | 11.71 | 12.04 | 10.07 | -2.1 | -3.99 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 13.45 | -15.82 | -50.5 | 17.36 | -11.32 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 13.26 | -9.24 | -41.99 | 13.2 | -9.9 | |||||
Dividend Per Share, 5 Yr. CAGR % | 24.3 | 15.38 | 9.86 | 5.5 | 3.55 |
- Stock Market
- Equities
- TSN Stock
- Financials Tyson Foods, Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















